Reported 0 shares, down 342,084 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 158000 |
| 2022-03-31 | 142000 |
| 2022-06-30 | 88000 |
| 2022-09-30 | 56000 |
| 2022-12-31 | 37800 |
| 2023-03-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q1 2023 | Reduced | 0 | -342,084 (-100.0%) | 0 | $0 | 2023-05-12 | |
| Q4 2022 | Added | 342,084 | +1,973 (0.6%) | < 0.01% | $37,800 | 2023-02-13 | |
| Q3 2022 | Reduced | 340,111 | -6,795 (-2.0%) | < 0.01% | $56,000 | 2022-11-14 | |
| Q2 2022 | Added | 346,906 | +79,083 (29.5%) | < 0.01% | $88,000 | 2022-08-12 | |
| Q1 2022 | Added | 267,823 | +9,703 (3.8%) | < 0.01% | $142,000 | 2022-05-16 | |
| Q4 2021 | Added | 258,120 | +7,825 (3.1%) | < 0.01% | $158,000 | 2022-02-14 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
63 managers reported CORBUS PHARMACEUTICALS HLDG for Q1 2023.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| IFP Advisors Inc | Added | 100 | +86 | < 0.01% | $595 | 5 qtrs |
| MORGAN STANLEY | Reduced | 0 | -83,430 | 0 | $0 | 32 qtrs |
| Aries Wealth Management | Reduced | 0 | -15,400 | 0 | $0 | 22 qtrs |
| JPMorgan Chase & Co | Reduced | 0 | -43,415 | 0 | $0 | 22 qtrs |
| Accel Wealth Management | Reduced | 0 | -1,383 | 0 | $0 | 4 qtrs |
| MASSMUTUAL TRUST CO FSB ADV | Reduced | 0 | -500 | 0 | $0 | 3 qtrs |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | Reduced | 0 | -99,416 | 0 | $0 | 24 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Reduced | 0 | -986,072 | 0 | $0 | 31 qtrs |
| Neuberger Berman Group LLC | Reduced | 0 | -20,000 | 0 | $0 | 5 qtrs |
| Kestra Advisory Services LLC | Reduced | 0 | -16,800 | 0 | $0 | 11 qtrs |
Filing details and methodology As reported
- Report period
- March 31, 2023
- Filed
- May 12, 2023
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.